130 results on '"Jiang, Jingzhi"'
Search Results
2. Numerical study on the melting performance of PCM by fractal fins in three-tube heat storage system
3. miR-181-5p attenuates neutrophilic inflammation in asthma by targeting DEK
4. Protective effects of glaucocalyxin A on the airway of asthmatic mice
5. Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways
6. Polydatin inhibits mitochondrial damage and mitochondrial ROS by promoting PINK1‐Parkin ‐mediated mitophagy in allergic rhinitis
7. Additional file 1 of Gene expression profiles and bioinformatics analysis in lung samples from ovalbumin-induced asthmatic mice
8. Analysis of Differentially Expressed MicroRNAs in OVA-induced Airway Remodeling Mice Model
9. Panax notoginseng saponin R1 attenuates allergic rhinitis through AMPK/Drp1 mediated mitochondrial fission
10. MicroRNA-182-5p Attenuates Asthmatic Airway Inflammation by Targeting NOX4
11. Sesamin Alleviates Asthma Airway Inflammation by Regulating Mitophagy and Mitochondrial Apoptosis
12. Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3β Signaling Pathway
13. Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK/Sirt1 and Nrf2/HO‐1 pathways
14. Numerical simulation of the fluid dynamics within the tissue engineering scaffolds micro-tubes
15. Analysis of Differentially Expressed MicroRNAs in OVA-induced Airway Remodeling Model Mice.
16. 43315 Improvements in Skin Clearance and Patient-Reported Outcomes were Greater with Guselkumab Compared with Ustekinumab Among Patients with Persistent Mild Psoriasis After 16- Weeks of Treatment with Ustekinumab
17. Preparation and characterization of microporous poly(vinyl butyral) membranes by supercritical CO 2-induced phase separation
18. Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways
19. S1PR2 Inhibition Attenuates Allergic Asthma Possibly by Regulating Autophagy
20. Preparation of erythromycin microparticles by supercritical fluid expansion depressurization
21. Study on heat transfer enhancement of solar finned tube phase change regenerator
22. Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3β Signaling Pathway.
23. Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator–controlled VOYAGE 1/2 trials.
24. DEK‐targeting aptamer DTA‐64 attenuates bronchial EMT‐mediated airway remodelling by suppressing TGF‐β1/Smad, MAPK and PI3K signalling pathway in asthma
25. Recombinant Pyrin Domain Protein Attenuates Airway Inflammation and Alleviates Epithelial-Mesenchymal Transition by Inhibiting Crosstalk Between TGFβ1 and Notch1 Signaling in Chronic Asthmatic Mice
26. Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator–controlled VOYAGE 1/2 trials
27. Imperatorin alleviates ROS-mediated airway remodeling by targeting the Nrf2/HO-1 signaling pathway
28. Numerical simulation and analysis of enhanced heat transfer in corrugated tube heat exchanger
29. Pterostilbene Inhibits FcεRI Signaling through Activation of the LKB1/AMPK Pathway in Allergic Response
30. Cryptotanshinone attenuates allergic airway inflammation through negative regulation of NF-κB and p38 MAPK
31. Cryptotanshinone Attenuates Airway Remodeling by Inhibiting Crosstalk Between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Transforming Growth Factor Beta 1 Signaling Pathways in Asthma
32. Study on enhancing heat transfer performance of spiral groove tube in phase change heat storage for solar energy
33. Consistent responses with guselkumab treatment in Asian and non‐Asian patients with psoriasis: An analysis from VOYAGE 1 and VOYAGE 2
34. Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study
35. Imperatorin Suppresses Anaphylactic Reaction and IgE-Mediated Allergic Responses by Inhibiting Multiple Steps of FceRI Signaling in Mast Cells: IMP Alleviates Allergic Responses in PCA
36. Recombinant pyrin domain protein attenuates allergic inflammation by suppressing NF-κB pathway in asthmatic mice
37. Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study.
38. Protective Effect and Mechanism of Alprostadil in Acute Respiratory Distress Syndrome Induced by Oleic Acid in Rats
39. Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial
40. Preparation of tetracycline microparticles suitable for inhalation administration by supercritical fluid expansion depressurization
41. Preparation of griseofulvin microparticles by supercritical fluid expansion depressurization process
42. Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways
43. Change of Rin1 and Stathmin in the Animal Model of Traumatic Stresses
44. Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial.
45. Recombinant pyrin domain protein attenuates allergic inflammation by suppressing NF‐κB pathway in asthmatic mice.
46. Cornuside inhibits mast cell-mediated allergic response by down-regulating MAPK and NF-κB signaling pathways
47. Preparation and characterization of microporous poly(vinyl butyral) membranes by supercritical CO2-induced phase separation
48. Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways
49. Preparation and characterization of microporous poly(vinyl butyral) membranes by supercritical CO2-induced phase separation
50. Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.